Reports
Reports
The oral antiseptics market has seen the unveiling of formulations with a wide range of microbial activity. These are extensively used for dental care and cleaning in humans as well as for pets. Further, their demands in veterinary dentistry in dental and oral surgical procedures are boosting the market. Emergence of new periodontal pathogens has also propelled the demand for better formulations in oral antiseptics. The oral antiseptics market has seen widespread commercialization in the rising use of antiseptic mouth rinses in controlling plaque and gingivitis. In the past few years, the dental care community has benefitted from a growing body of research in understanding the risk and effectiveness of various formulations being marketed. The oral antiseptics market is also seeing a growing demand in veterinary dentistry, notably in chronic feline gingivostomatitis.
Some of the key compositions of the products in the oral antiseptics market are chlorhexidine gluconate, methyl salicylate, povidone-iodine, hydrogen peroxide, cetylpyridinium chloride, and essential oils. Key distribution channels are drugstores, retail pharmacies, and supermarkets/hypermarkets. In recent years, e-commerce is emerging as an attractive channel for distributors.
Growing use of oral antiseptics in oral surgery and dental care routines is a key factor driving the oral antiseptics market. In animals, non-alcoholic oral antiseptics have gathered steady traction over the past few years. Growing significance of effective antiplaquing activity is a key trend boosting the oral antiseptics market.
Growing awareness about dental and oral health in worldwide populations has reinforced the potential demands in the oral antiseptics market. This is due to awareness about dental caries and gingivitis. In emerging economies over the past decade, the use of antiseptic mouth rinses has gathered noticeable traction among populations. New commercially marketed products with better active ingredients are gathering steam in the oral antiseptics market. World over, the growing incidence of chronic gingivitis is a key factor boosting the market.
New regulatory guidelines seek to assess new antimicrobial strategies for oral care and other infectious agents. This will likely open new avenues in the oral antiseptics market. The relevance of oral antiseptics and their superiority over antibiotics have found some mention recently in draft guidelines by the National Institute for Health and Care Excellence (NICE). In a recent disclosure, NICE has stated that oral antiseptics can turn out to be better than antiseptics in localised, non-bullous impetigo in certain cases. This has brought oral antiseptics as a good alternative for people who usually take topical antibiotics for the contagious skin disease impetigo.
Several other research studies have focused on characterizing clinically used oral antiseptics. Growing understanding of general practitioners have progressed on the back of such studies, expanding the potential of the oral antiseptics market. A growing number of oral antiseptics manufacturers are also making concerted efforts to raise awareness about oral diseases in humans and pets.
Some of the prominent players in the oral antiseptics market are:
On the regional front, the oral antiseptics market is seeing prospects in North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. Of these, North America and Europe have come out as key regional markets owing to the considerable demand prospects in dental and veterinary care. Constant efforts to develop new formulations by players in these regions have also augmented their overall potential. Further, populations in several developed countries in these regions are increasingly aware of the importance of routine oral care to prevent oral diseases.
N/A
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Oral Antiseptics Market
